Legal status · United States
Is Retatrutide legal in the United States?
No. Retatrutide is not approved for any medical use in the United States; its classification is "Investigational, not approved for any indication". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.
Retatrutide in the United States at a glance
| Classification | Investigational, not approved for any indication |
|---|---|
| FDA approval status | Investigational, not FDA-approved; Phase 3 TRIUMPH-1 reported May 2026; submission expected late 2026 |
| Evidence level | Moderate (research strength: Moderate) |
| Reviewed | Sep 2026 |
Classification and note come from the Retatrutide profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
Retatrutide is being studied in registered clinical trials but has not received FDA marketing approval in the United States.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What Retatrutide is
An investigational once-weekly triple receptor agonist producing the largest pharmacological weight loss reported to date in trials.
Retatrutide is an investigational triple agonist targeting the GLP-1, GIP, and glucagon receptors. Phase 2 trials reported up to ~24% body weight reduction at the highest dose.
Mechanism: Agonizes GLP-1, GIP, and glucagon receptors. The added glucagon activity increases energy expenditure and hepatic fat oxidation, complementing the appetite and insulin effects of the incretin receptors.
Regulatory history: Investigational, not FDA-approved; Phase 3 TRIUMPH-1 reported May 2026; submission expected late 2026
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Retatrutide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Retatrutide in other countries
Frequently asked questions
Is Retatrutide legal in the United States?
No. Retatrutide is not approved for any medical use in the United States; its classification is "Investigational, not approved for any indication". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. Human evidence to date: Moderate.
Can I buy Retatrutide in the United States?
No approved product exists to buy. In the United States Retatrutide is classified as "Investigational, not approved for any indication", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Retatrutide FDA approved?
No. FDA status: Investigational, not FDA-approved; Phase 3 TRIUMPH-1 reported May 2026; submission expected late 2026. Current US classification: "Investigational, not approved for any indication". Evidence level: Moderate.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Retatrutide live on its compound profile.
Retatrutide profileThis page is general information about the regulatory status of Retatrutide in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.